The .8-adrenergic receptor kinase (.BARK) is the prototypical member of the family of cytosolic kinases that phosphorylate guanine nucleotide binding-protein-coupled receptors and thereby trigger uncoupling between receptors and guanine nucleotide binding proteins. Herein we show that this kinase is subject to phosphorylation and regulation by protein kinase C (PKC). In cell lines stably expressing GIBadrenergic receptors, activation of these receptors by epinephrine resulted in an activation of cytosolic f3ARK. Similar data were obtained in 293 cells transiently coexpressing a1B-adrenergic receptors and 8ARK-1. Direct activation of PKC with phorbol esters in these cells caused not only an activation of cytosolic ,BARK-1 but also a translocation of .8ARK immunoreactivity from the cytosol to the membrane fraction. A PKC preparation purified from rat brain phosphorylated purified recombinant pARK-1 to a stoichiometry of 0.86 phosphate per 8ARK-1. This phosphorylation resulted in an increased activity of .8ARK-1 when membrane-bound rhodopsin served as its substrate but in no increase of its activity toward a soluble peptide substrate. The site of phosphorylation was mapped to the C terminus of f8ARK-1. We conclude that PKC activates DARK by enhancing its translocation to the plasma membrane.
Signaling via guanine nucleotide binding (G)-protein-coupled receptors is initiated by binding of agonist ligands and is mediated by the activation of G proteins, which involves binding of GTP by the a subunit and its dissociation from the f,y-subunit complex (1, 2) . Both the a subunit and the 13y-subunit complex can then regulate effector molecules and thereby produce intracellular signals (3, 4) . This signaling pathway is subject to a variety of regulatory mechanisms that alter the expression and the function of the proteins involved. One of the key regulatory processes is the desensitization of such receptors in response to prolonged or repeated agonist exposure. Various mechanisms contribute to receptor desensitization (5, 6) . The most rapid and probably quantitatively the most important one (7, 8) is triggered by phosphorylation of the receptors by members of the family of G-protein-coupled receptor kinases. Of the six members of this family cloned to date (9) , the f3-adrenergic receptor kinase-1 (,3ARK-1; ref. 10) has been studied as the prototypical member that mediates receptor desensitization. Desensitization by this kinase occurs as a two-step process: (i) The kinase translocates from the cytosol to the plasma membrane (11) and phosphorylates several serine and threonine residues in the cytoplasmic portions of the receptors. (ii) Members of another family of cytosolic proteins, the arrestins, bind to the phosphorylated receptors and thereby impair the receptor-Gprotein interaction (12) (13) (14) . Much interest has recently been concerned with the mode of translocation of P3ARK to the plasma membrane. Three anchoring points have been identiThe publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
fied that are used for membrane attachment: the agonistoccupied receptor (15) , the G-protein f3y subunits (16) (17) (18) , and phosphatidylinositol bisphosphate (19) . The agonistactivated receptors and the G-protein f3y subunits have been reported to cause activation of the kinase (15, 20) , but no such activation has been observed by other authors (19) for the G-protein fry subunits and for phosphatidylinositol bisphosphate. Thus, P3ARK appears to be regulated essentially by the availability of the substrate (since only the agonist-occupied form of receptors is a substrate) and of the membrane anchors. In many other kinases, there are multiple mechanisms that regulate the kinase activity, for example, via phosphorylation of the kinase, but no such mechanisms have so far been identified for P3ARK.
In addition to ,BARK, two other kinases have been found to be capable of phosphorylating f32-adrenergic receptors, i.e., protein kinase A and protein kinase C (PKC). These kinases phosphorylate sites in the third intracellular loop and in the C terminus of the receptor, which causes direct impairment of receptor-G, coupling without the participation of arrestins (21) (22) (23) (24) . In the present study, we identify a cross-talk between PKC and P3ARK by showing that PKC directly phosphorylates ,BARK and causes its activation by translocation to the membrane. These studies were initiated by attempts to investigate whether ,BARK can also phosphorylate receptors that couple via Gq to phospholipase C, such as the alB-adrenergic receptor (alB-AR), and whether, therefore, activation of these receptors would also induce translocation of P3ARK to the membrane as had been shown for Gs-coupled receptors. While we found no evidence for such a type of translocation, we discovered that aiB-AR regulates ,BARK via activation of PKC.
MATERIALS AND METHODS
Generation of CHO Cells Stably Expressing the alB-AR. An expression plasmid for the hamster alB-AR, pBC-al (25) The stimulation was stopped by removal of the medium and addition of 3 ml of ice-cold phosphate-buffered saline, which was also used for two similar washing steps. Subsequently, the cells were scraped off in 20 mM Tris HCl, pH 7.4/50 mM NaCl/2 mM EDTA and disrupted with an Ultraturrax device. Intact cells and cell debris was removed by centrifugation at 500 x g for 5 min, and the supernatant was separated into a cytosolic and a particulate membrane fraction by centrifugation at 130,000 x g for 30 min. In some experiments, the supernatant fraction was adsorbed on DEAE-Sepharose to reduce the levels of other kinases and the remaining supernatant containing P3ARK was then concentrated on Amicon-30 devices.
Determination of pARK Activity. PARK activity was determined by using urea-treated rod outer segments (50 pmol of rhodopsin) as the substrate as described (29) with or without 50 nM purified G-protein 3-y-subunits. The incubation was carried out at 30°C for 15 min. The 32p incorporation into rhodopsin was determined by excision of the rhodopsin band after SDS/polyacrylamide gel electrophoresis and Cerenkov counting. Alternatively, PARK activity was determined with the peptide RRREEEEESAAA (1.5 mM) as the substrate according to Onorato et al. (30) .
Determination of JBARK Immunoreactivity. An antiserum against f3ARK-1 was generated by immunization of rabbits with purified recombinant 3ARK-1. P3ARK immunoreactivity was measured by Western blot analysis using this antiserum (1:2000 dilution) and peroxidase-coupled second antibodies (Dianova) plus ECL reagents (Amersham).
Phosphorylation of Purified 8fARK-1 by Purified PKC. A PKC preparation purified from rat brain was prepared according to Kikkawa et al. (31) . Approximately 250 ng of this preparation (-3 pmol of PKC) was incubated with 10 pmol of purified recombinant f3ARK-1 in the presence of urea-treated rod outer segments (2 ,ug of protein) or 4 ,ug of crude phosphatidylcholine (type 11-S from soybean) vesicles (32) Proteins were resolved by SDS/polyacrylamide gel electrophoresis and visualized by autoradiography. 32p incorporation was quantitated by Cerenkov counting of the excised bands.
Expression and Purification of the C Terminus of BARK-1. The cDNA sequence coding for the C terminus of human ,ARK-1 (amino acids 552-689) was cloned into the vector pGEXlAT (Pharmacia), which allowed its expression as a glutathione S-transferase (GST) fusion protein and its purification over glutathione-agarose using 10 mM glutathione for the elution. The purity of these preparations was >95%.
Purification of Proteins. G-protein fry subunits were purified from bovine brain according to Sternweis and Robishaw (33) . Human ,BARK-1 was expressed in Sf9 cells and purified according to Sohlemann et al. (29) . The concentration of these proteins was determined according to Bradford (34) .
RESULTS
To investigate whether stimulation of amB-AR altered the activity or cellular distribution of ,BARK, we generated a CHO-cell line stably expressing the aII-AR at a density of 0.39 ± 0.04 pmol/mg of membrane protein. Functional activity of these receptors was demonstrated by the ability of epinephrine to enhance inositol phosphate production >5-fold, whereas no such effect was observed in nontransfected CHO cells (data not shown). In these cells, we examined the effects of stimulation of the a113-AR with epinephrine for various times on the cytosolic ,BARK activity. In contrast to the reduction of cytosolic PARK activity caused by stimulation of 32-adrenergic receptors (11) , stimulation of aII-AR in these cells resulted in a rapid and sustained increase of cytosolic ,BARK activity (Fig. 1) . This increase occurred as early as 30 sec after the addition of epinephrine, was maximal after 1 min with an increase by -130%, and was maintained for about 20 min.
Mediation of this effect by the transfected acI3-AR was suggested by the observations that it was absent in nontransfected CHO cells, that it occurred with an appropriate EC50 value of 10 ,tM, and that it could be blocked by the aII3-AR antagonist prazosin (data not shown).
To be able to monitor the subcellular distribution of P3ARK immunoreactivity, we generated 293 cells transiently expressing both al-AR and PARK-1. In these cell lines, stimulation of aII-AR resulted in a similar increase of cytosolic P3ARK activity (data not shown). Direct activation of PKC, the target kinase of the alB-AR, with 1 ,uM PMA for 20 min caused an increase of specific P3ARK activity in the cytosol, but at the same time a marked reduction of the cytosolic ,BARK immunoreactivity (Fig. 2) . The reduction of ,BARK immunoreactivity was >50% after 20 min (Fig. 2A) of membrane-associated P3ARK could not be reliably detected, since in these cells basal P3ARK immunoreactivity in the membrane fraction was too high. The activity of the remaining cytosolic ,BARK was increased 2.3-fold (Fig. 2B) .
These data suggested that activation of PKC might lead to activation of ,BARK and concomitantly to a reduction of cytosolic ,BARK. We then investigated whether such effects might be due to a direct interaction between the two kinases. Coincubation of PKC purified from rat brain with purified recombinant ,BARK-1 in the presence of phospholipid vesicles and phorbol ester led to an enhanced phosphorylation of an -80-kD band, which contains both PKC and f3ARK-1 (Fig.   3A) . The phosphorylation in the presence of both kinases was much larger than the sum of phosphorylation of each kinase alone. Precipitation of J3ARK-1 with a specific antiserum after the reaction indicated that the phosphorylation did indeed occur on P3ARK-1 (Fig. 3B) . The stoichiometry of phosphorylation of ,BARK-1 in these experiments was calculated at 0.86 + 0.27 phosphates per ,BARK-1. PKC-catalyzed phosphorylation of ,BARK-1 was confirmed by the observation that the PKC inhibitor staurosporine markedly reduced this phosphorylation (Fig. 3C) .
The PKC-catalyzed phosphorylation of ,3ARK-1 resulted in its activation when rhodopsin was used as its substrate: The phosphorylation of rhodopsin by f3ARK-1 was markedly increased in the presence of PKC (Fig. 4) . This increase was independent of the enhancing effects of G-protein f3y subunits in this assay, since PKC caused an increase of 2.9 + 0.6 times in the absence, and an increase of 2.4 + 0.4 times in the presence of fy subunits. Again, the enhancement was inhibited by staurosporine indicating that it was caused by PKCcatalyzed phosphorylation. Heparin, a nonselective PARK inhibitor, reduced the phosphorylation of rhodopsin to the low levels seen with PKC alone. This suggests that the enhancing effects of PKC were mediated via !ARK-1 and that direct phosphorylation of rhodopsin by PKC was modest.
To test whether these effects were due to an enhancement of P3ARK-1 catalytic activity, the soluble peptide RRREEEEESAAA was used as the substrate. In these assays, PKC caused no activation of ,BARK-1 (Table 1 ). In fact, the presence of PKC even caused a reduction in the ,BARK-1-mediated phosphorylation of the peptide. This suggests that the PKC-mediated activation seen with rhodopsin as the substrate was not due to enhanced catalytic activity but was possibly due to improved membrane targeting.
The C terminus of PARK-1 is the domain responsible for membrane attachment since it binds both G-protein fry subunits and phosphatidylinositol bisphosphate (19) . If PKC affects the membrane attachment, then it would appear likely that phosphorylation of f3ARK-1 occurs at the C terminus. A clear consensus sequence for PKC remains to be defined; according to the criteria of Kennelly and Krebs (35) , the C terminus of ,3ARK-1 contains four suboptimal PKC phosphorylation motifs with arginine or lysine residues 1-3 positions Nor C-terminal of a serine/threonine residue. Indeed, the j3ARK-1 C terminus expressed as a GST fusion protein proved to be a very good substrate for PKC (Fig. 5) . The stoichiometry of phosphorylation was similar to that of the entire ,BARK-1, suggesting that a single relevant phosphorylation site for PKC is located in this C terminus.
DISCUSSION
Activation of different types of Gs-coupled receptors causes a translocation of P3ARK activity from the cytosol to membranes (11, 36, 37) . Since P3ARK has also been shown to phosphorylate receptors coupled to other G proteins, such as the Gi-coupled a2-adrenergic and the m2-muscarinic acetylcholine receptors and the Gq-coupled substance P receptors (38-40), we speculated that stimulation of the Gq-coupled alB-AR might cause a similar translocation of PARK. Such a transloBiochemistry: Winstel et al. with inhibitors and phosphorylation of the isolated C terminus of ,BARK-1 indicated that the PKC-induced increase in phosphorylation and activity of ,ARK-1 was indeed due to PKCcatalyzed phosphorylation and not due to PKC-induced enhancement of ,BARK-1 autophosphorylation.
Most of the C terminus of PARK is formed by a pleckstrin homology domain, which together with a C-terminally adjacent a-helix has been implicated in binding to G-protein fry subunits as well as to phosphatidylinositol bisphosphate (19) . Two other kinases that contain a pleckstrin homology domain, Bruton tyrosine kinase and RAC (related to A-and C-kinase) kinase, have been shown to interact with PKC (41, 42) . In the case of Bruton tyrosine kinase, this interaction has been studied also at the functional level and has been found to cause decreased enzymatic activity of the kinase. Thus, the activation of PARK by PKC must be caused by another mechanism. Indeed, the catalytic activity of P3ARK was even decreased when a soluble peptide was used as the substrate. This suggests that the increased activity toward rhodopsin, a membranebound substrate, might be due to enhanced membrane targeting of the kinase. This hypothesis is compatible with the observation that in intact cells PARK levels in the cytosol were indeed reduced after activation of PKC.
Our findings suggest that in addition to substrate availability and membrane attachment, there is a third level of regulation for ,BARK: phosphorylation-mediated membrane translocation. Such a chain of phosphorylation (PKC -> PARK -> receptor) can explain the observation that desensitization of odorant receptors can be inhibited either by heparin or by PKC inhibitors (43 (1996) meinschaft, the European Commission, and the Fonds der Chemischen Industrie.
